148 related articles for article (PubMed ID: 7376319)
1. [Characteristics of the ototoxic action of aminoglycoside and peptide antibiotics on tuberculosis patients].
Shesterina MV; Kolesova LI
Vestn Otorinolaringol; 1980; (1):5-8. PubMed ID: 7376319
[No Abstract] [Full Text] [Related]
2. [The prevention of ototoxic hearing lesions].
Samoĭlova IG
Med Sestra; 1991 Oct; 50(10):51-3. PubMed ID: 1803199
[No Abstract] [Full Text] [Related]
3. [Ultrasonic lateralization test in the diagnosis of early forms of sensorineural hearing loss].
Kolesova LI
Vestn Otorinolaringol; 1983; (3):20-3. PubMed ID: 6868264
[No Abstract] [Full Text] [Related]
4. [Pathomorphological aspects of the action of aminoglycoside antibiotics on the acoustic analyzer].
Zhuravskiĭ SG; Tomson VV; Tsvyleva ID; Ivanov AG
Vestn Otorinolaringol; 2003; (2):55-60. PubMed ID: 12958868
[No Abstract] [Full Text] [Related]
5. [Hearing loss caused by aminoglycoside antibiotics: affect on the membrane component PIP2 in outer hair cells as the mechanism of action].
Zenner HP; Schacht J
HNO; 1986 Oct; 34(10):417-23. PubMed ID: 3025138
[TBL] [Abstract][Full Text] [Related]
6. [Ototoxicity of aminoglycoside antibiotics: an alternative in sight?].
Ruppersberg JP
HNO; 1997 Mar; 45(3):111-2. PubMed ID: 9417430
[No Abstract] [Full Text] [Related]
7. [Hearing loss, a complication of antibiotic therapy in severely burned patients].
Bauer M; Zanon E; Balogh D; Rauchegger H
Handchir Mikrochir Plast Chir; 1987 May; 19(3):125-8. PubMed ID: 3596366
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside ototoxicity.
Rizzi MD; Hirose K
Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):352-7. PubMed ID: 17823553
[TBL] [Abstract][Full Text] [Related]
9. [Ototoxic drugs. I. Aminoglycoside antibiotics].
Buszman E; Wrześniok D; Matusiński B
Wiad Lek; 2003; 56(5-6):254-9. PubMed ID: 14526485
[TBL] [Abstract][Full Text] [Related]
10. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
de Jager P; van Altena R
Int J Tuberc Lung Dis; 2002 Jul; 6(7):622-7. PubMed ID: 12102302
[TBL] [Abstract][Full Text] [Related]
11. [Iatrogenic and environmentally-induced hearing disorders in advanced age].
Albegger K
Fortschr Med; 1984 Mar; 102(10):247-51. PubMed ID: 6714890
[TBL] [Abstract][Full Text] [Related]
12. The frequency in New Zealand of a mitochondrial DNA mutation (1555 A to G) associated with aminoglycoside-induced hearing loss.
Scrimshaw BJ; Faed JM; Tate WP; Yun K
N Z Med J; 1999 Jun; 112(1089):216-7. PubMed ID: 10414625
[No Abstract] [Full Text] [Related]
13. [The effect of polikatan on the ototoxic action of kanamycin].
Spasov AA; Lobzov MS; Sanzharovskaia NK; Kozhevnikova EV; Kuzubova EA
Eksp Klin Farmakol; 1999; 62(4):65-6. PubMed ID: 10513342
[TBL] [Abstract][Full Text] [Related]
14. [Hearing and the vestibular function in pulmonary tuberculosis during antibacterial therapy].
Miasnikov VG; Mishchanchuk NS
Probl Tuberk; 1980 Nov; (11):38-42. PubMed ID: 6969886
[No Abstract] [Full Text] [Related]
15. [Vestibulometry in prognosis of lesions of the organ of hearing after administration of aminoglycoside antibiotics].
Bazarov VG; Mishchanchuk NS
Zh Ushn Nos Gorl Bolezn; 1978; (6):21-7. PubMed ID: 216180
[No Abstract] [Full Text] [Related]
16. [Ototoxicity of aminoglycoside antibiotics].
Reiss M; Reiss G
Praxis (Bern 1994); 2003 Jan; 92(4):127-33. PubMed ID: 12632843
[TBL] [Abstract][Full Text] [Related]
17. Ototoxic agents.
Marlowe FI
Otolaryngol Clin North Am; 1978 Oct; 11(3):791-800. PubMed ID: 733260
[No Abstract] [Full Text] [Related]
18. Characteristics of ototoxicity of aminoglycosides "locked" to prevent hemodialysis catheter-related infections.
Saxena AK
Hemodial Int; 2006 Jan; 10(1):94. PubMed ID: 16441834
[No Abstract] [Full Text] [Related]
19. Biochemistry and pharmacology of aminoglycoside-induced hearing loss.
Schacht J
Acta Physiol Pharmacol Ther Latinoam; 1999; 49(4):251-6. PubMed ID: 10797868
[TBL] [Abstract][Full Text] [Related]
20. [Effects of aminoglycoside antibiotics on various structures of the acoustic analyzer].
Fisenko VP
Eksp Klin Farmakol; 2003; 66(2):42-5. PubMed ID: 12962047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
